Schizophrenia Clinical Trials in New York

Showing 161-180 of 187 trials

Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia

NCT00802100

This study will compare the safety and effectiveness of three different antipsychotic medications, as well as the use of other medications to limit treatment side effects, in adults with schizophrenia.

Schizophrenia

National Institute of Mental Health (NIMH)21 participantsStarted Dec 2008

Colton, California, United States • Palo Alto, California, United States • New Haven, Connecticut, United States +10 more locations

TERMINATEDPhase 2/3< 1 mile

A Long-Term, Open-Label, Study on Schizophrenia

NCT01129674

The primary purpose of the study is to help answer the following research questions: How LY 2140023 can be tolerated by patients with Schizophrenia compared to standard of care treatment in 52 weeks time period. Whether LY 2140023 can help patients with Schizophrenia.

Schizophrenia

Eli Lilly and Company1,210 participantsStarted Jun 2010

Little Rock, Arkansas, United States • Escondido, California, United States • Garden Grove, California, United States +78 more locations

Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia

A Long-Term, Open-Label, Study on Schizophrenia

Schizophrenia Trials in Other Cities

CAFE Comparison of Atypicals in First Episode of Psychosis

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

Treatment for First-Episode Schizophrenia

Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Clozapine and Olanzapine Treatment of Aggression

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Other Conditions in New York